Phillip Paul Minar

18PUBLICATIONS
73CO-AUTHORS
PharmacogenomicsInfant and child healthPharmaceutical delivery technologiesAutoimmunityChild and adolescent development
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jul 26, 2026
Pharmacometric Targets During Anti-TNF Induction and Their Association with Deep Remission in Pediatric Crohn's Disease.

|Jun 30, 2026
The Safety and Effectiveness of Early Anti-Tumor-Necrosis-Factor Therapy for Penetrating Crohn's Disease Complications in Children.

|Nov 24, 2025
CAPTURE IBD: Advancing Precision Medicine in Pediatric IBD.

Shova Subedi, Lindsey G Albenbergl, Julie A Bass

|Nov 05, 2025
Model-Informed Deep Q-Networks to Guide Infliximab Dosing in Pediatric Crohn's Disease.

Kei Irie, Phillip Minar, Jack Reifenberg

|Jun 04, 2025
Comment on a Risk Stratification Tool for Relapse After Intravenous-to-Subcutaneous Switching of Infliximab in Patients With Inflammatory Bowel Diseases.

Thomas Aviles, Phillip Minar

|May 02, 2025
HLA DQA1*05 and Risk of Antitumor Necrosis Factor Treatment Failure and Anti-Drug Antibody Development in Children With Crohn's Disease.

Jeremy Adler, Joseph A Galanko, Rana Ammoury

Pageof 3

Frequent Collaborators

4 joint publications

Tomoyuki Mizuno

3 joint publications

Ruben J Colman

3 joint publications

Jeffrey S Hyams

3 joint publications

Alexander A Vinks